Royal Bank Of Canada Fsd Pharma Inc. Transaction History

Royal Bank Of Canada

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.6 $1,369 - $2,048	-1,280 Reduced 58.82%	896 $1,000
Q2 2023 Aug 14, 2023	BUY	$0.99 - $2.04 $365 - $752	369 Added 20.42%	2,176 $2,000
Q1 2023 May 15, 2023	SELL	$0.77 - $1.81 $626 - $1,471	-813 Reduced 31.03%	1,807 $2,000
Q4 2022 Feb 14, 2023	BUY	$0.73 - $1.07 $116 - $170	159 Added 6.46%	2,620 $2,000
Q3 2022 Nov 14, 2022	SELL	$0.78 - $1.02 $792 - $1,036	-1,016 Reduced 29.22%	2,461 $2,000

Q2 2022 Aug 15, 2022	BUY	$0.78 - $1.1 $871 - $1,228	1,117 Added 47.33%	3,477 $3,000
Q1 2022 May 16, 2022	BUY	$0.82 - $1.1 $1,360 - $1,824	1,659 Added 236.66%	2,360 $3,000
Q4 2021 Feb 14, 2022	SELL	$0.96 - $1.63 $200 - $340	-209 Reduced 22.97%	701 $1,000
Q3 2021 Nov 15, 2021	BUY	$1.45 - $1.84 $39 - $49	27 Added 3.06%	910 $1,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $2.13 $1,377 - $1,880	883 New	883 $1,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $5.35M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.